Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Pathology|April 1, 1995
Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reactionL Lespagnard, P Cochaux, D Larsimont, et al.
Cancer Gene Therapy|December 29, 2000
The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapyC Grignet-Debrus, V Cool, N Baudson, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015)W A Schroyens, P F Dodion, C Sanders, et al.
Immunology|August 1, 1997
Interleukin-10 modulates susceptibility in experimental cerebral malariaS Kossodo, C Monso, P Juillard, et al.
Scandinavian Journal of Haematology|September 1, 1983
Increased levels of myeloid progenitor cells in the blood of patients with metastatic invasion of the marrowA Delforge, J P De Caluwe, E Rongé-Collard, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1993
Lack of intrathyroidal tumor necrosis factor alpha in Graves' diseaseR Paschke, A Kist, R Jänicke, et al.
Haematologica|September 1, 1990
The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformationM Antimi, M Masi, A Delannoy, et al.
Revue Medicale De Bruxelles|August 5, 2004
[New therapeutic approachs in melanoma]L Mortier, P Marchetti, L Gordower, et al.
International Journal of Cancer|October 15, 1990
Over-expression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotypeE M Valverius, T Velu, V Shankar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia GroupB Löwenberg, R Zittoun, H Kerkhofs, et al.
Pageof 12